Drug intelligence / Profile preview

Levulan Kerastick + BLU-U Blue Light Photodynamic Therapy Illuminator

Development stage
Unknown
Lead developer
DUSA Pharmaceuticals
Modality
Small Molecules, Device-based Delivery → Drug Delivery Systems
Administration
Topical
01

Overview

The Levulan Kerastick + BLU-U Blue Light Photodynamic Therapy Illuminator is a drug-device combination therapy used for the treatment of actinic keratoses and the prevention of non-melanoma skin cancer. The system utilizes Levulan Kerastick (aminolevulinic acid HCl 20% topical solution), a prodrug that is topically applied and metabolized intracellularly into the potent photosensitizer protoporphyrin IX (PpIX). Following an incubation period, the treated area is exposed to visible blue light (400-450 nm) from the BLU-U illuminator. This light activates the PpIX, leading to the generation of reactive oxygen species, primarily singlet oxygen, which causes selective destruction of abnormal or precancerous cells. This modality is particularly evaluated for cyclic preventative use in high-risk populations, such as solid organ transplant recipients.

Brand names
Levulan KerastickBLU-U
Other names
Levulan PDTALA-PDTaminolevulinic acid HCl 20% topical solution + blue light

Beyond the preview

Go deeper on Levulan Kerastick + BLU-U Blue Light Photodynamic Therapy Illuminator.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Levulan Kerastick + BLU-U Blue Light Photodynamic Therapy Illuminator.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call